Connection

MARGARET SPITZ to Humans

This is a "connection" page, showing publications MARGARET SPITZ has written about Humans.
Connection Strength

1.414
  1. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
    View in: PubMed
    Score: 0.016
  2. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
    View in: PubMed
    Score: 0.013
  3. BRCA2-branching out too? J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.013
  4. The authors reply. Am J Epidemiol. 2015 Mar 01; 181(5):361.
    View in: PubMed
    Score: 0.012
  5. The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol. 2014 Nov 15; 180(10):964-7.
    View in: PubMed
    Score: 0.012
  6. Exposure to pro-tobacco messages and smoking status among Mexican origin youth. J Immigr Minor Health. 2014 Jun; 16(3):385-93.
    View in: PubMed
    Score: 0.012
  7. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
    View in: PubMed
    Score: 0.011
  8. Sensation-seeking genes and physical activity in youth. Genes Brain Behav. 2013 Mar; 12(2):181-8.
    View in: PubMed
    Score: 0.011
  9. Integrative cancer epidemiology--the next generation. Cancer Discov. 2012 Dec; 2(12):1087-90.
    View in: PubMed
    Score: 0.011
  10. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.010
  11. Experimenting with cigarettes and physical activity among Mexican origin youth: a cross sectional analysis of the interdependent associations among sensation seeking, acculturation, and gender. BMC Public Health. 2012 May 04; 12:332.
    View in: PubMed
    Score: 0.010
  12. Cotinine conundrum--a step forward but questions remain. J Natl Cancer Inst. 2012 May 16; 104(10):720-2.
    View in: PubMed
    Score: 0.010
  13. Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):228-38.
    View in: PubMed
    Score: 0.010
  14. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.010
  15. Epidemiology--found in translation. Cancer Discov. 2011 Jun; 1(1):21-2.
    View in: PubMed
    Score: 0.010
  16. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):900-11.
    View in: PubMed
    Score: 0.010
  17. 'Confounding' our future. Cancer Epidemiol Biomarkers Prev. 2011 Apr; 20(4):578-9.
    View in: PubMed
    Score: 0.010
  18. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205.
    View in: PubMed
    Score: 0.009
  19. The evolving discipline of molecular epidemiology of cancer. Carcinogenesis. 2010 Jan; 31(1):127-34.
    View in: PubMed
    Score: 0.009
  20. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.009
  21. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage. 2009 Dec; 38(6):894-902.
    View in: PubMed
    Score: 0.009
  22. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics. 2008 Nov; 18(11):955-65.
    View in: PubMed
    Score: 0.008
  23. Influence of subjective social status on the relationship between positive outcome expectations and experimentation with cigarettes. J Adolesc Health. 2009 Apr; 44(4):342-8.
    View in: PubMed
    Score: 0.008
  24. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.008
  25. Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: a cross-sectional analysis. BMC Public Health. 2008 Sep 26; 8:337.
    View in: PubMed
    Score: 0.008
  26. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Dec 01; 178(11):1164-72.
    View in: PubMed
    Score: 0.008
  27. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4.
    View in: PubMed
    Score: 0.008
  28. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila). 2008 Sep; 1(4):255-65.
    View in: PubMed
    Score: 0.008
  29. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008 Aug; 21(8):950-60.
    View in: PubMed
    Score: 0.008
  30. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
    View in: PubMed
    Score: 0.008
  31. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.007
  32. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007 Jul 01; 67(13):6520-7.
    View in: PubMed
    Score: 0.007
  33. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.007
  34. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
    View in: PubMed
    Score: 0.007
  35. Age-related differences in factors associated with smoking initiation. Cancer Causes Control. 2007 Aug; 18(6):635-44.
    View in: PubMed
    Score: 0.007
  36. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 2007 Apr 15; 67(8):3493-5.
    View in: PubMed
    Score: 0.007
  37. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis. 2007 Jul; 28(7):1430-6.
    View in: PubMed
    Score: 0.007
  38. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7194-201.
    View in: PubMed
    Score: 0.007
  39. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006 Jun 15; 66(12):6449-56.
    View in: PubMed
    Score: 0.007
  40. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.007
  41. An epidemiologic study of early onset lung cancer. Lung Cancer. 2006 May; 52(2):129-34.
    View in: PubMed
    Score: 0.007
  42. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.007
  43. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):158-61.
    View in: PubMed
    Score: 0.007
  44. Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol. 2006 Feb 15; 163(4):394-5; author reply 395-6.
    View in: PubMed
    Score: 0.007
  45. Dietary phytoestrogens and lung cancer risk. JAMA. 2005 Sep 28; 294(12):1493-504.
    View in: PubMed
    Score: 0.007
  46. Wood dust exposure and the association with lung cancer risk. Am J Ind Med. 2005 Apr; 47(4):349-57.
    View in: PubMed
    Score: 0.006
  47. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8.
    View in: PubMed
    Score: 0.006
  48. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar 01; 161(5):412-22.
    View in: PubMed
    Score: 0.006
  49. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol. 2005 Jan 10; 23(2):267-75.
    View in: PubMed
    Score: 0.006
  50. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57.
    View in: PubMed
    Score: 0.006
  51. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004 Dec 15; 101(12):2837-42.
    View in: PubMed
    Score: 0.006
  52. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004 Dec; 31(6):726-33.
    View in: PubMed
    Score: 0.006
  53. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
    View in: PubMed
    Score: 0.006
  54. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):113-23.
    View in: PubMed
    Score: 0.006
  55. Subgroup report: head and neck cancer. IARC Sci Publ. 2004; (157):41-7.
    View in: PubMed
    Score: 0.006
  56. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003 Dec 01; 63(23):8531-5.
    View in: PubMed
    Score: 0.006
  57. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):963-9.
    View in: PubMed
    Score: 0.006
  58. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
    View in: PubMed
    Score: 0.006
  59. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.006
  60. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):689-98.
    View in: PubMed
    Score: 0.006
  61. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 2023 05 26; 14(1):3043.
    View in: PubMed
    Score: 0.006
  62. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9.
    View in: PubMed
    Score: 0.005
  63. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003 Mar; 14(2):131-8.
    View in: PubMed
    Score: 0.005
  64. Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003; 75:121-33.
    View in: PubMed
    Score: 0.005
  65. Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk. Methods Mol Med. 2003; 75:279-87.
    View in: PubMed
    Score: 0.005
  66. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1413-8.
    View in: PubMed
    Score: 0.005
  67. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):758-66.
    View in: PubMed
    Score: 0.005
  68. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 2022 08; 54(8):1167-1177.
    View in: PubMed
    Score: 0.005
  69. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1091-9.
    View in: PubMed
    Score: 0.005
  70. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8.
    View in: PubMed
    Score: 0.005
  71. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.005
  72. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 2022 03 10; 40(8):876-883.
    View in: PubMed
    Score: 0.005
  73. Lung cancer chemoprevention: an integrated approach. J Clin Oncol. 2001 Sep 15; 19(18 Suppl):74S-82S.
    View in: PubMed
    Score: 0.005
  74. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8.
    View in: PubMed
    Score: 0.005
  75. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. Am J Hum Genet. 2021 04 01; 108(4):564-582.
    View in: PubMed
    Score: 0.005
  76. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001 Feb 15; 61(4):1354-7.
    View in: PubMed
    Score: 0.005
  77. Leptin and prostate cancer. Prostate. 2001 Jan 01; 46(1):62-7.
    View in: PubMed
    Score: 0.005
  78. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000 Nov 01; 92(21):1764-72.
    View in: PubMed
    Score: 0.005
  79. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20.
    View in: PubMed
    Score: 0.005
  80. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1021-6.
    View in: PubMed
    Score: 0.005
  81. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.004
  82. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000 May 03; 92(9):737-43.
    View in: PubMed
    Score: 0.004
  83. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S26-7.
    View in: PubMed
    Score: 0.004
  84. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer. 1999 May; 80(3-4):453-7.
    View in: PubMed
    Score: 0.004
  85. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 08; 14(8):1360-1369.
    View in: PubMed
    Score: 0.004
  86. Molecular dosimeters of smoking damage in the lung. J Natl Cancer Inst. 1999 Apr 07; 91(7):578-9.
    View in: PubMed
    Score: 0.004
  87. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):715-723.
    View in: PubMed
    Score: 0.004
  88. Viewing images of alcohol use in PG-13-rated movies and alcohol initiation in Mexican-heritage youth. J Ethn Subst Abuse. 2020 Oct-Dec; 19(4):521-536.
    View in: PubMed
    Score: 0.004
  89. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res. 1999; 151:3-12.
    View in: PubMed
    Score: 0.004
  90. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest. 1999; 17(8):645-59.
    View in: PubMed
    Score: 0.004
  91. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 1998 Dec; 9(6):545-52.
    View in: PubMed
    Score: 0.004
  92. Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. Hum Mol Genet. 2018 11 01; 27(21):3801-3812.
    View in: PubMed
    Score: 0.004
  93. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer. 1998 Oct 23; 79(5):490-3.
    View in: PubMed
    Score: 0.004
  94. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9.
    View in: PubMed
    Score: 0.004
  95. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 1998 Sep 15; 83(6):1118-27.
    View in: PubMed
    Score: 0.004
  96. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8.
    View in: PubMed
    Score: 0.004
  97. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998 Mar 04; 90(5):358-63.
    View in: PubMed
    Score: 0.004
  98. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5.
    View in: PubMed
    Score: 0.004
  99. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8.
    View in: PubMed
    Score: 0.004
  100. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.004
  101. PACE-setting research. Lancet. 1997 Sep 06; 350(9079):677-8.
    View in: PubMed
    Score: 0.004
  102. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92.
    View in: PubMed
    Score: 0.004
  103. The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 1997 Sep-Dec; 16(3-4):295-307.
    View in: PubMed
    Score: 0.004
  104. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug; 6(8):565-71.
    View in: PubMed
    Score: 0.004
  105. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):537-42.
    View in: PubMed
    Score: 0.004
  106. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017 Jul; 49(7):1126-1132.
    View in: PubMed
    Score: 0.004
  107. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 1997 May; 18(5):967-73.
    View in: PubMed
    Score: 0.004
  108. Health care's double standard: the prevention dilemma. J Public Health Manag Pract. 1997 May; 3(3):37-42.
    View in: PubMed
    Score: 0.004
  109. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. Cancer. 1997 Apr 15; 79(8):1527-32.
    View in: PubMed
    Score: 0.004
  110. Case-control assessment of diet and lung cancer risk in African Americans and Mexican Americans. Nutr Cancer. 1997; 29(2):169-73.
    View in: PubMed
    Score: 0.004
  111. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996 Sep 15; 56(18):4103-7.
    View in: PubMed
    Score: 0.003
  112. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996 Sep 01; 56(17):3975-9.
    View in: PubMed
    Score: 0.003
  113. Month-of-birth and incidence of acute lymphoblastic leukemia in children. Leuk Lymphoma. 1996 Sep; 23(1-2):85-92.
    View in: PubMed
    Score: 0.003
  114. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine. 2016 Sep; 11:219-226.
    View in: PubMed
    Score: 0.003
  115. Clinical and genetic investigation of a Brazilian family with Huntington's disease. Funct Neurol. 2016 Jul-Sep; 31(3):135-42.
    View in: PubMed
    Score: 0.003
  116. Mutagen sensitivity exhibits a dose-response relationship in case-control studies. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5(7):577-8.
    View in: PubMed
    Score: 0.003
  117. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016 06 13; 7:11843.
    View in: PubMed
    Score: 0.003
  118. Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer. 2016 08; 98:33-42.
    View in: PubMed
    Score: 0.003
  119. Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016 Feb; 4:153-61.
    View in: PubMed
    Score: 0.003
  120. Mutagen sensitivity as a marker of cancer susceptibility. J Cell Biochem Suppl. 1996; 25:80-4.
    View in: PubMed
    Score: 0.003
  121. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 2015 Nov; 36(11):1314-26.
    View in: PubMed
    Score: 0.003
  122. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.003
  123. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep; 4(6):583-8.
    View in: PubMed
    Score: 0.003
  124. Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. J Natl Cancer Inst. 2015 Nov; 107(11).
    View in: PubMed
    Score: 0.003
  125. Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth. BMC Med Genet. 2015 Jun 26; 16:43.
    View in: PubMed
    Score: 0.003
  126. Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer. 2015 Nov 01; 137(9):2155-62.
    View in: PubMed
    Score: 0.003
  127. Smoking Initiation Among Mexican Heritage Youth and the Roles of Family Cohesion and Conflict. J Adolesc Health. 2015 Jul; 57(1):24-30.
    View in: PubMed
    Score: 0.003
  128. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.003
  129. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.003
  130. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.003
  131. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect. 2015 Jun; 123(6):507-14.
    View in: PubMed
    Score: 0.003
  132. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 1995 Feb 01; 55(3):557-61.
    View in: PubMed
    Score: 0.003
  133. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 2015 Feb 05; 96(2):301-8.
    View in: PubMed
    Score: 0.003
  134. Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer. Genet Epidemiol. 2015 Mar; 39(3):197-206.
    View in: PubMed
    Score: 0.003
  135. Improving residents' knowledge of cancer prevention: are physicians prepared for prevention? J Cancer Educ. 1995; 10(1):9-13.
    View in: PubMed
    Score: 0.003
  136. Risk factors and genetic susceptibility. Cancer Treat Res. 1995; 74:73-87.
    View in: PubMed
    Score: 0.003
  137. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr. 1995; (18):29-33.
    View in: PubMed
    Score: 0.003
  138. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 2015 Jan; 36(1):99-103.
    View in: PubMed
    Score: 0.003
  139. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.003
  140. Education and lung cancer among never smokers. Epidemiology. 2014 Nov; 25(6):934-5.
    View in: PubMed
    Score: 0.003
  141. Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. Am J Hum Genet. 2014 Oct 02; 95(4):437-44.
    View in: PubMed
    Score: 0.003
  142. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2462-70.
    View in: PubMed
    Score: 0.003
  143. A risk prediction model for smoking experimentation in Mexican American youth. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2165-74.
    View in: PubMed
    Score: 0.003
  144. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.003
  145. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014 Dec; 14(6):509-22.
    View in: PubMed
    Score: 0.003
  146. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1729-51.
    View in: PubMed
    Score: 0.003
  147. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis. 1994 Jun; 15(6):1121-4.
    View in: PubMed
    Score: 0.003
  148. Epidemiology and risk factors for head and neck cancer. Semin Oncol. 1994 Jun; 21(3):281-8.
    View in: PubMed
    Score: 0.003
  149. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41.
    View in: PubMed
    Score: 0.003
  150. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369.
    View in: PubMed
    Score: 0.003
  151. Mutagen sensitivity as a marker of cancer risk. Cancer Detect Prev. 1994; 18(4):299-303.
    View in: PubMed
    Score: 0.003
  152. Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. Genet Epidemiol. 2013 Dec; 37(8):846-59.
    View in: PubMed
    Score: 0.003
  153. Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health. 2013 Oct; 15(5):910-7.
    View in: PubMed
    Score: 0.003
  154. Cancer risk and early detection assessment. Semin Oncol Nurs. 1993 Aug; 9(3):188-97.
    View in: PubMed
    Score: 0.003
  155. Genetic susceptibility to cancer. Cancer. 1993 Aug 01; 72(3 Suppl):991-5.
    View in: PubMed
    Score: 0.003
  156. Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. BMC Med. 2013 Jul 19; 11:168.
    View in: PubMed
    Score: 0.003
  157. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer. 2013 Nov; 21(11):3117-25.
    View in: PubMed
    Score: 0.003
  158. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug; 2(4):329-33.
    View in: PubMed
    Score: 0.003
  159. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.003
  160. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.
    View in: PubMed
    Score: 0.003
  161. The associations of body image, anxiety, and smoking among Mexican-origin youth. J Adolesc Health. 2013 Aug; 53(2):209-14.
    View in: PubMed
    Score: 0.003
  162. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013 Apr 16; 14(4):8381-92.
    View in: PubMed
    Score: 0.003
  163. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet. 2013 Jun; 45(6):690-6.
    View in: PubMed
    Score: 0.003
  164. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):508-16.
    View in: PubMed
    Score: 0.003
  165. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
    View in: PubMed
    Score: 0.003
  166. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475.
    View in: PubMed
    Score: 0.003
  167. Cigarette experimentation and the population attributable fraction for associated genetic and non-genetic risk factors. PLoS One. 2013; 8(1):e53868.
    View in: PubMed
    Score: 0.003
  168. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):181-8.
    View in: PubMed
    Score: 0.003
  169. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.003
  170. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):135-45.
    View in: PubMed
    Score: 0.003
  171. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug; 46(2):161-72.
    View in: PubMed
    Score: 0.003
  172. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 2012 Nov; 3(11):1428-38.
    View in: PubMed
    Score: 0.003
  173. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.003
  174. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705.
    View in: PubMed
    Score: 0.003
  175. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91.
    View in: PubMed
    Score: 0.003
  176. AACR Cancer Progress Report 2012. Clin Cancer Res. 2012 Nov 01; 18(21 Suppl):S1-100.
    View in: PubMed
    Score: 0.003
  177. Association between malignancies of the upper aerodigestive tract and uterine cervix. Head Neck. 1992 Sep-Oct; 14(5):347-51.
    View in: PubMed
    Score: 0.003
  178. Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). Addict Behav. 2013 Jan; 38(1):1485-92.
    View in: PubMed
    Score: 0.003
  179. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012 Nov 15; 21(22):4980-95.
    View in: PubMed
    Score: 0.003
  180. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry. 2012 Aug; 69(8):854-60.
    View in: PubMed
    Score: 0.003
  181. Chapter 11: Rice-MD Anderson lung cancer model. Risk Anal. 2012 Jul; 32 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.003
  182. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis. 2012 Aug; 33(8):1531-7.
    View in: PubMed
    Score: 0.003
  183. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 01; 18(13):3705-13.
    View in: PubMed
    Score: 0.003
  184. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.003
  185. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.003
  186. Derived SNP alleles are used more frequently than ancestral alleles as risk-associated variants in common human diseases. J Bioinform Comput Biol. 2012 Apr; 10(2):1241008.
    View in: PubMed
    Score: 0.003
  187. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012 May 16; 104(10):778-89.
    View in: PubMed
    Score: 0.003
  188. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012 Sep; 48(13):1957-68.
    View in: PubMed
    Score: 0.003
  189. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control. 2012 Mar; 23(3):487-96.
    View in: PubMed
    Score: 0.003
  190. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One. 2012; 7(2):e31816.
    View in: PubMed
    Score: 0.003
  191. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012 May 15; 175(10):1013-20.
    View in: PubMed
    Score: 0.003
  192. Genetic and environmental interactions as risks for aerodigestive cancers. Adv Exp Med Biol. 1992; 320:31-4.
    View in: PubMed
    Score: 0.003
  193. Cancer prevention practices among Texas primary care physicians. J Cancer Educ. 1992; 7(1):55-60.
    View in: PubMed
    Score: 0.003
  194. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol. 2012 Mar; 138(3):377-85.
    View in: PubMed
    Score: 0.002
  195. Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov. 2012 Feb; 2(2):131-9.
    View in: PubMed
    Score: 0.002
  196. Familial patterns of prostate cancer: a case-control analysis. J Urol. 1991 Nov; 146(5):1305-7.
    View in: PubMed
    Score: 0.002
  197. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9.
    View in: PubMed
    Score: 0.002
  198. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. Mutagenesis. 2012 May; 27(3):267-73.
    View in: PubMed
    Score: 0.002
  199. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71.
    View in: PubMed
    Score: 0.002
  200. DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol. 2011 Nov 01; 29(31):4121-8.
    View in: PubMed
    Score: 0.002
  201. Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50.
    View in: PubMed
    Score: 0.002
  202. Gender differences in sociodemographic and behavioral influences of physical activity in Mexican-origin adolescents. J Phys Act Health. 2012 Aug; 9(6):829-39.
    View in: PubMed
    Score: 0.002
  203. Dietary patterns affect lung cancer risk in never smokers. Nutr Cancer. 2011; 63(6):842-9.
    View in: PubMed
    Score: 0.002
  204. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
    View in: PubMed
    Score: 0.002
  205. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.002
  206. The PhenX Toolkit: get the most from your measures. Am J Epidemiol. 2011 Aug 01; 174(3):253-60.
    View in: PubMed
    Score: 0.002
  207. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.002
  208. Ethyl alcohol as a cocarcinogen with special reference to the aerodigestive tract: a cytogenetic study. Anticancer Res. 1991 May-Jun; 11(3):1097-101.
    View in: PubMed
    Score: 0.002
  209. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6.
    View in: PubMed
    Score: 0.002
  210. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25.
    View in: PubMed
    Score: 0.002
  211. Psychosocial risk and correlates of early menarche in Mexican-American girls. Am J Epidemiol. 2011 May 15; 173(10):1203-10.
    View in: PubMed
    Score: 0.002
  212. A smoking-based carcinogenesis model for lung cancer risk prediction. Int J Cancer. 2011 Oct 15; 129(8):1907-13.
    View in: PubMed
    Score: 0.002
  213. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. DNA Repair (Amst). 2011 Apr 03; 10(4):398-407.
    View in: PubMed
    Score: 0.002
  214. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
    View in: PubMed
    Score: 0.002
  215. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93.
    View in: PubMed
    Score: 0.002
  216. Risk profiles of women with cervical neoplasia. J Cancer Educ. 1991; 6(4):241-6.
    View in: PubMed
    Score: 0.002
  217. Variants in folate pathway genes as modulators of genetic instability and lung cancer risk. Genes Chromosomes Cancer. 2011 Jan; 50(1):1-12.
    View in: PubMed
    Score: 0.002
  218. Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. J Adolesc Health. 2011 Jan; 48(1):65-72.
    View in: PubMed
    Score: 0.002
  219. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
    View in: PubMed
    Score: 0.002
  220. Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg. 1990 Oct; 116(10):1163-6.
    View in: PubMed
    Score: 0.002
  221. Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet. 2011 Mar; 79(3):199-206.
    View in: PubMed
    Score: 0.002
  222. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23.
    View in: PubMed
    Score: 0.002
  223. Leukemia and cigarette smoking. Cancer Causes Control. 1990 Sep; 1(2):195-6.
    View in: PubMed
    Score: 0.002
  224. Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans. Cancer Causes Control. 2010 Dec; 21(12):2157-64.
    View in: PubMed
    Score: 0.002
  225. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402.
    View in: PubMed
    Score: 0.002
  226. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer. 2010 Aug 18; 10:439.
    View in: PubMed
    Score: 0.002
  227. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010 Aug 05; 6(8).
    View in: PubMed
    Score: 0.002
  228. GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol. 2010 Aug; 11(8):714-6; author reply 716.
    View in: PubMed
    Score: 0.002
  229. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
    View in: PubMed
    Score: 0.002
  230. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62.
    View in: PubMed
    Score: 0.002
  231. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer. 2010 Jul 27; 103(3):423-9.
    View in: PubMed
    Score: 0.002
  232. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.002
  233. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One. 2010 May 28; 5(5):e10858.
    View in: PubMed
    Score: 0.002
  234. A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 15; 16(14):3779-85.
    View in: PubMed
    Score: 0.002
  235. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer. 2011 Jan; 71(1):82-8.
    View in: PubMed
    Score: 0.002
  236. Chipping away at the genetics of smoking behavior. Nat Genet. 2010 May; 42(5):366-8.
    View in: PubMed
    Score: 0.002
  237. Salivary gland cancer and risk of subsequent skin cancer. Head Neck. 1990 May-Jun; 12(3):254-6.
    View in: PubMed
    Score: 0.002
  238. Early cancer detection: update for primary-care physicians. Tex Med. 1990 Apr; 86(4):44-7.
    View in: PubMed
    Score: 0.002
  239. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010 Apr; 11(4):321-30.
    View in: PubMed
    Score: 0.002
  240. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.002
  241. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ. 1990; 5(2):109-13.
    View in: PubMed
    Score: 0.002
  242. Cigarette smoking patterns of cancer patients. Prog Clin Biol Res. 1990; 339:73-82.
    View in: PubMed
    Score: 0.002
  243. Exposure to smoking imagery in the movies and experimenting with cigarettes among Mexican heritage youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3435-43.
    View in: PubMed
    Score: 0.002
  244. Cognitive susceptibility to smoking: Two paths to experimenting among Mexican origin youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3459-67.
    View in: PubMed
    Score: 0.002
  245. Childhood nervous system tumours: an assessment of risk associated with paternal occupations involving use, repair or manufacture of electrical and electronic equipment. Int J Epidemiol. 1989 Dec; 18(4):756-62.
    View in: PubMed
    Score: 0.002
  246. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009 11; 85(5):679-91.
    View in: PubMed
    Score: 0.002
  247. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2636-42.
    View in: PubMed
    Score: 0.002
  248. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989 Aug 15; 49(16):4626-8.
    View in: PubMed
    Score: 0.002
  249. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009 Aug 15; 69(16):6633-41.
    View in: PubMed
    Score: 0.002
  250. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24.
    View in: PubMed
    Score: 0.002
  251. Maternal current smoking: concordance between adolescent proxy and mother's self-report. Nicotine Tob Res. 2009 Aug; 11(8):1016-9.
    View in: PubMed
    Score: 0.002
  252. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009 May; 49(5):1563-70.
    View in: PubMed
    Score: 0.002
  253. Encouraging trends in lung cancer mortality in Texas, 1970 to 1986. Tex Med. 1989 Mar; 85(3):42-4.
    View in: PubMed
    Score: 0.002
  254. Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009; 24(1):58-64.
    View in: PubMed
    Score: 0.002
  255. The implementation and applications of a cancer patient risk evaluation questionnaire. Prog Clin Biol Res. 1989; 293:263-70.
    View in: PubMed
    Score: 0.002
  256. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008 Dec; 40(12):1407-9.
    View in: PubMed
    Score: 0.002
  257. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95.
    View in: PubMed
    Score: 0.002
  258. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3081-9.
    View in: PubMed
    Score: 0.002
  259. The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3262-7.
    View in: PubMed
    Score: 0.002
  260. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.
    View in: PubMed
    Score: 0.002
  261. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.002
  262. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer. 1988 Oct 15; 42(4):549-53.
    View in: PubMed
    Score: 0.002
  263. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008 Sep 17; 100(18):1326-30.
    View in: PubMed
    Score: 0.002
  264. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 01; 123(5):1173-80.
    View in: PubMed
    Score: 0.002
  265. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.
    View in: PubMed
    Score: 0.002
  266. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12.
    View in: PubMed
    Score: 0.002
  267. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.002
  268. The development of a comprehensive, institution-based patient risk evaluation program: I. Development, content, and data management. Am J Prev Med. 1988 Jul-Aug; 4(4):183-7.
    View in: PubMed
    Score: 0.002
  269. The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med. 1988 Jul-Aug; 4(4):188-93.
    View in: PubMed
    Score: 0.002
  270. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11.
    View in: PubMed
    Score: 0.002
  271. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer. 2008 Jun 15; 112(12):2756-64.
    View in: PubMed
    Score: 0.002
  272. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med. 2008 Jun; 10(6):369-84.
    View in: PubMed
    Score: 0.002
  273. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res. 2008 Jun 01; 68(11):4479-85.
    View in: PubMed
    Score: 0.002
  274. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.002
  275. Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988 May-Jun; 10(5):305-8.
    View in: PubMed
    Score: 0.002
  276. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1111-9.
    View in: PubMed
    Score: 0.002
  277. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008 May; 29(5):949-56.
    View in: PubMed
    Score: 0.002
  278. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. Br J Cancer. 2008 May 20; 98(10):1716-22.
    View in: PubMed
    Score: 0.002
  279. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008 May; 40(5):616-22.
    View in: PubMed
    Score: 0.002
  280. Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. Am J Epidemiol. 2008 May 01; 167(9):1070-80.
    View in: PubMed
    Score: 0.002
  281. Pelvic adhesions in intrauterine device users. Obstet Gynecol. 1988 Feb; 71(2):251-4.
    View in: PubMed
    Score: 0.002
  282. Profiles of cigarette smoking among patients in a cancer center. J Cancer Educ. 1988; 3(4):265-71.
    View in: PubMed
    Score: 0.002
  283. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer. 1988 Jan 01; 61(1):203-8.
    View in: PubMed
    Score: 0.002
  284. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008 Jan; 82(1):100-12.
    View in: PubMed
    Score: 0.002
  285. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2756-62.
    View in: PubMed
    Score: 0.002
  286. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer. 2007 Nov 15; 121(10):2254-9.
    View in: PubMed
    Score: 0.002
  287. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007 Dec 06; 450(7171):893-8.
    View in: PubMed
    Score: 0.002
  288. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res. 2007 Oct 01; 13(19):5974-81.
    View in: PubMed
    Score: 0.002
  289. Maternal BMI and country of birth as indicators of childhood obesity in children of Mexican origin. Obesity (Silver Spring). 2007 Oct; 15(10):2512-9.
    View in: PubMed
    Score: 0.002
  290. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):2065-71.
    View in: PubMed
    Score: 0.002
  291. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007 Sep 01; 67(17):8406-11.
    View in: PubMed
    Score: 0.002
  292. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75.
    View in: PubMed
    Score: 0.002
  293. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.002
  294. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22.
    View in: PubMed
    Score: 0.002
  295. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8.
    View in: PubMed
    Score: 0.002
  296. Re: Identifying Mexican Americans. Am J Epidemiol. 1987 Jun; 125(6):1094.
    View in: PubMed
    Score: 0.002
  297. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer. 2007 Aug; 57(2):143-51.
    View in: PubMed
    Score: 0.002
  298. Birthplace, years of residence in the United States, and obesity among Mexican-American adults. Obesity (Silver Spring). 2007 Apr; 15(4):1043-52.
    View in: PubMed
    Score: 0.002
  299. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med. 2007 Apr; 4(4):e125.
    View in: PubMed
    Score: 0.002
  300. Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer. 2007 Mar 15; 109(6):1157-63.
    View in: PubMed
    Score: 0.002
  301. Dietary zinc, copper and selenium, and risk of lung cancer. Int J Cancer. 2007 Mar 01; 120(5):1108-15.
    View in: PubMed
    Score: 0.002
  302. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9.
    View in: PubMed
    Score: 0.002
  303. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007 Feb; 9(2):67-73.
    View in: PubMed
    Score: 0.002
  304. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Dec 15; 12(24):7329-38.
    View in: PubMed
    Score: 0.002
  305. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2364-9.
    View in: PubMed
    Score: 0.002
  306. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis. 2007 May; 28(5):988-94.
    View in: PubMed
    Score: 0.002
  307. Incidence and descriptive features of testicular cancer among United States whites, blacks, and Hispanics, 1973-1982. Cancer. 1986 Oct 15; 58(8):1785-90.
    View in: PubMed
    Score: 0.002
  308. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Oct 01; 12(19):5720-5.
    View in: PubMed
    Score: 0.002
  309. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1935-40.
    View in: PubMed
    Score: 0.002
  310. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006 Dec 01; 164(11):1027-42.
    View in: PubMed
    Score: 0.002
  311. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.002
  312. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
    View in: PubMed
    Score: 0.002
  313. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis. 2007 Feb; 28(2):350-5.
    View in: PubMed
    Score: 0.002
  314. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11.
    View in: PubMed
    Score: 0.002
  315. Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutat Res. 2006 Oct 10; 601(1-2):1-10.
    View in: PubMed
    Score: 0.002
  316. Lung and breast cancer death rates in Texas women. Tex Med. 1986 Aug; 82(8):44-6.
    View in: PubMed
    Score: 0.002
  317. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006 Jun 15; 106(12):2636-44.
    View in: PubMed
    Score: 0.002
  318. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97.
    View in: PubMed
    Score: 0.002
  319. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res. 2006 Jun 15; 66(12):5993-6.
    View in: PubMed
    Score: 0.002
  320. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct; 27(10):2028-33.
    View in: PubMed
    Score: 0.002
  321. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7.
    View in: PubMed
    Score: 0.002
  322. Sex ratio of offspring of patients with prostatic cancer. CMAJ. 1986 Jan 15; 134(2):104-5.
    View in: PubMed
    Score: 0.002
  323. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7.
    View in: PubMed
    Score: 0.002
  324. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.002
  325. Questionable relationship between cholecystectomy and colon cancer. J Surg Oncol. 1985 Sep; 30(1):6-9.
    View in: PubMed
    Score: 0.002
  326. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):547-55.
    View in: PubMed
    Score: 0.002
  327. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):557-64.
    View in: PubMed
    Score: 0.002
  328. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
    View in: PubMed
    Score: 0.002
  329. Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol. 2005 Jul 01; 23(19):4439-49.
    View in: PubMed
    Score: 0.002
  330. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6.
    View in: PubMed
    Score: 0.002
  331. Neuroblastoma and paternal occupation. A case-control analysis. Am J Epidemiol. 1985 Jun; 121(6):924-9.
    View in: PubMed
    Score: 0.002
  332. Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. Am J Public Health. 2005 Jun; 95(6):1043-9.
    View in: PubMed
    Score: 0.002
  333. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1477-84.
    View in: PubMed
    Score: 0.002
  334. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.002
  335. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7.
    View in: PubMed
    Score: 0.002
  336. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005 Sep; 26(9):1596-602.
    View in: PubMed
    Score: 0.002
  337. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005 May; 79(5):1704-10.
    View in: PubMed
    Score: 0.002
  338. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
    View in: PubMed
    Score: 0.002
  339. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res. 2005 Apr 15; 11(8):2894-8.
    View in: PubMed
    Score: 0.002
  340. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8.
    View in: PubMed
    Score: 0.002
  341. The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):764-7.
    View in: PubMed
    Score: 0.002
  342. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84.
    View in: PubMed
    Score: 0.002
  343. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1034-6.
    View in: PubMed
    Score: 0.002
  344. Multiple primary cancer risk in patients with major salivary gland carcinoma. Ann Otol Rhinol Laryngol. 1985 Mar-Apr; 94(2 Pt 1):129-32.
    View in: PubMed
    Score: 0.002
  345. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):748-52.
    View in: PubMed
    Score: 0.002
  346. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005 Mar; 15(3):159-65.
    View in: PubMed
    Score: 0.002
  347. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53(2):127-34.
    View in: PubMed
    Score: 0.002
  348. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51.
    View in: PubMed
    Score: 0.002
  349. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis. 2005 Mar; 26(3):649-56.
    View in: PubMed
    Score: 0.002
  350. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89.
    View in: PubMed
    Score: 0.002
  351. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):330-8.
    View in: PubMed
    Score: 0.002
  352. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9.
    View in: PubMed
    Score: 0.002
  353. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004 Dec 01; 10(23):7903-10.
    View in: PubMed
    Score: 0.002
  354. Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet. 2005 Jan; 116(1-2):121-7.
    View in: PubMed
    Score: 0.002
  355. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer. 1984 Nov 01; 54(9):1854-9.
    View in: PubMed
    Score: 0.002
  356. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.002
  357. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate. 2004 Sep 01; 60(4):343-51.
    View in: PubMed
    Score: 0.002
  358. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet. 2004 Aug; 5(8):589-97.
    View in: PubMed
    Score: 0.002
  359. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.001
  360. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.001
  361. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3.
    View in: PubMed
    Score: 0.001
  362. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8.
    View in: PubMed
    Score: 0.001
  363. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47.
    View in: PubMed
    Score: 0.001
  364. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar 15; 64(6):2251-7.
    View in: PubMed
    Score: 0.001
  365. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
    View in: PubMed
    Score: 0.001
  366. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984 Jan; 110(1):45-9.
    View in: PubMed
    Score: 0.001
  367. Comparison of haplotype inference methods using genotypic data from unrelated individuals. Hum Hered. 2004; 58(2):63-8.
    View in: PubMed
    Score: 0.001
  368. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol. 2003 Dec; 121(6):1510-4.
    View in: PubMed
    Score: 0.001
  369. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.001
  370. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer. 2003 Oct 15; 98(8):1701-6.
    View in: PubMed
    Score: 0.001
  371. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003 Oct 01; 98(7):1457-64.
    View in: PubMed
    Score: 0.001
  372. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer. 2003 Oct; 42(1):1-8.
    View in: PubMed
    Score: 0.001
  373. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61.
    View in: PubMed
    Score: 0.001
  374. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst). 2003 Aug 12; 2(8):901-8.
    View in: PubMed
    Score: 0.001
  375. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.001
  376. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7.
    View in: PubMed
    Score: 0.001
  377. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7.
    View in: PubMed
    Score: 0.001
  378. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr; 40(1):25-32.
    View in: PubMed
    Score: 0.001
  379. Development of common data elements: the experience of and recommendations from the early detection research network. Int J Med Inform. 2003 Apr; 70(1):41-8.
    View in: PubMed
    Score: 0.001
  380. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9.
    View in: PubMed
    Score: 0.001
  381. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis. Mol Carcinog. 2003 Mar; 36(3):123-9.
    View in: PubMed
    Score: 0.001
  382. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.001
  383. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
    View in: PubMed
    Score: 0.001
  384. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. Int J Cancer. 2002 Dec 10; 102(5):536-40.
    View in: PubMed
    Score: 0.001
  385. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res. 2002 Nov 30; 509(1-2):165-74.
    View in: PubMed
    Score: 0.001
  386. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1142-3.
    View in: PubMed
    Score: 0.001
  387. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002 Sep 26; 183(2):123-30.
    View in: PubMed
    Score: 0.001
  388. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002 Sep 01; 62(17):4992-5.
    View in: PubMed
    Score: 0.001
  389. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
    View in: PubMed
    Score: 0.001
  390. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Cancer. 2002 Aug 01; 95(3):563-8.
    View in: PubMed
    Score: 0.001
  391. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul; 37(1):35-40.
    View in: PubMed
    Score: 0.001
  392. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):640-5.
    View in: PubMed
    Score: 0.001
  393. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 2002 Jul; 38(5):475-7.
    View in: PubMed
    Score: 0.001
  394. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37.
    View in: PubMed
    Score: 0.001
  395. Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet. 2002 Jul 01; 136(1):73-7.
    View in: PubMed
    Score: 0.001
  396. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.001
  397. Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer. 2002 Jun; 36(3):243-7.
    View in: PubMed
    Score: 0.001
  398. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002 Feb; 35(2):137-42.
    View in: PubMed
    Score: 0.001
  399. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog. 2002 Feb; 33(2):99-104.
    View in: PubMed
    Score: 0.001
  400. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis. 2002 Feb; 23(2):295-9.
    View in: PubMed
    Score: 0.001
  401. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002 Jan 15; 94(2):393-7.
    View in: PubMed
    Score: 0.001
  402. Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Cancer Detect Prev. 2002; 26(6):411-8.
    View in: PubMed
    Score: 0.001
  403. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res. 2001 Dec 01; 61(23):8465-9.
    View in: PubMed
    Score: 0.001
  404. Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. Carcinogenesis. 2001 Dec; 22(12):2005-8.
    View in: PubMed
    Score: 0.001
  405. Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. Am J Ind Med. 2001 Nov; 40(5):554-60.
    View in: PubMed
    Score: 0.001
  406. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 2001 Nov 01; 61(21):7819-24.
    View in: PubMed
    Score: 0.001
  407. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001 Nov 01; 61(21):7825-9.
    View in: PubMed
    Score: 0.001
  408. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001 Sep 20; 95(5):332-6.
    View in: PubMed
    Score: 0.001
  409. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33.
    View in: PubMed
    Score: 0.001
  410. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer. 2001 Aug 01; 93(3):436-40.
    View in: PubMed
    Score: 0.001
  411. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001 Aug; 22(8):1195-9.
    View in: PubMed
    Score: 0.001
  412. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001 Jul 15; 92(2):225-31.
    View in: PubMed
    Score: 0.001
  413. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. Prostate. 2001 Jun 01; 47(4):269-75.
    View in: PubMed
    Score: 0.001
  414. Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies. Cancer Lett. 2001 May 26; 166(2):155-63.
    View in: PubMed
    Score: 0.001
  415. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene. 2001 Apr 26; 20(18):2273-80.
    View in: PubMed
    Score: 0.001
  416. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001 Apr 15; 61(8):3321-5.
    View in: PubMed
    Score: 0.001
  417. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):397-401.
    View in: PubMed
    Score: 0.001
  418. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):273-5.
    View in: PubMed
    Score: 0.001
  419. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res. 2001 Feb 15; 61(4):1445-50.
    View in: PubMed
    Score: 0.001
  420. Comparative efficacy as antioxidants between ascorbic acid and epigallocatechin gallate on cells of two human lymphoblastoid lines. Cancer Genet Cytogenet. 2001 Jan 15; 124(2):169-71.
    View in: PubMed
    Score: 0.001
  421. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000 Dec; 21(12):2219-23.
    View in: PubMed
    Score: 0.001
  422. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000 Nov 15; 88(4):601-6.
    View in: PubMed
    Score: 0.001
  423. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol. 2000 Nov 01; 18(21 Suppl):9S-18S.
    View in: PubMed
    Score: 0.001
  424. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1043-9.
    View in: PubMed
    Score: 0.001
  425. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol. 2000 Aug; 17(2):399-404.
    View in: PubMed
    Score: 0.001
  426. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis. 2000 Aug; 21(8):1527-30.
    View in: PubMed
    Score: 0.001
  427. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res. 2000 Jul; 154(1):20-7.
    View in: PubMed
    Score: 0.001
  428. Statistical models for analysis of cytogenetic biomarkers. J Investig Med. 2000 Jul; 48(4):281-6.
    View in: PubMed
    Score: 0.001
  429. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000 Jun; 21(6):1163-6.
    View in: PubMed
    Score: 0.001
  430. Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer. 2000 Apr 15; 88(8):1837-41.
    View in: PubMed
    Score: 0.001
  431. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000 Jan; 27(1):34-46.
    View in: PubMed
    Score: 0.001
  432. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene. 1999 Dec 09; 18(52):7576-83.
    View in: PubMed
    Score: 0.001
  433. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1071-8.
    View in: PubMed
    Score: 0.001
  434. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 1999 Nov; 20(11):2125-9.
    View in: PubMed
    Score: 0.001
  435. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett. 1999 Nov 01; 146(1):93-101.
    View in: PubMed
    Score: 0.001
  436. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis. 1999 Aug; 20(8):1465-9.
    View in: PubMed
    Score: 0.001
  437. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer. 1999 Jun 21; 84(3):220-4.
    View in: PubMed
    Score: 0.001
  438. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet. 1999 Apr; 110(1):65-9.
    View in: PubMed
    Score: 0.001
  439. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6.
    View in: PubMed
    Score: 0.001
  440. Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer. 1999; 33(1):3-19.
    View in: PubMed
    Score: 0.001
  441. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999; 33(1):20-5.
    View in: PubMed
    Score: 0.001
  442. Correspondence re: M. T. Goodman et al., effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol. Biomark. Prev., 7: 113-117, 1998. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):729.
    View in: PubMed
    Score: 0.001
  443. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 1998 Jul 15; 83(2):204-12.
    View in: PubMed
    Score: 0.001
  444. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998 Jul; 4(7):1773-8.
    View in: PubMed
    Score: 0.001
  445. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 1998 Jul; 7(7):567-70.
    View in: PubMed
    Score: 0.001
  446. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):465-8.
    View in: PubMed
    Score: 0.001
  447. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1998 Apr; 7(4):309-14.
    View in: PubMed
    Score: 0.001
  448. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma. 1998 Feb; 28(5-6):561-6.
    View in: PubMed
    Score: 0.001
  449. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control. 1997 Jul; 8(4):554-9.
    View in: PubMed
    Score: 0.001
  450. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. Cancer Epidemiol Biomarkers Prev. 1997 Apr; 6(4):291-3.
    View in: PubMed
    Score: 0.001
  451. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst. 1997 Feb 05; 89(3):199-211.
    View in: PubMed
    Score: 0.001
  452. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997 Feb; 6(2):87-92.
    View in: PubMed
    Score: 0.001
  453. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer. 1997; 76(7):852-4.
    View in: PubMed
    Score: 0.001
  454. Lung carcinoma in former smokers. Cancer. 1996 Sep 01; 78(5):1004-10.
    View in: PubMed
    Score: 0.001
  455. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res. 1996 Aug 15; 56(16):3638-41.
    View in: PubMed
    Score: 0.001
  456. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev. 1996 Aug; 5(8):639-44.
    View in: PubMed
    Score: 0.001
  457. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5(7):527-32.
    View in: PubMed
    Score: 0.001
  458. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. Anticancer Res. 1996 May-Jun; 16(3A):1187-92.
    View in: PubMed
    Score: 0.001
  459. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996 Apr 17; 88(8):530-5.
    View in: PubMed
    Score: 0.001
  460. Sex chromosome abnormalities in lung cancer patients. Cancer Genet Cytogenet. 1996 Mar; 87(1):24-8.
    View in: PubMed
    Score: 0.001
  461. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev. 1996 Mar; 5(3):191-7.
    View in: PubMed
    Score: 0.001
  462. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev. 1996 Mar; 5(3):199-204.
    View in: PubMed
    Score: 0.001
  463. Glutathione s-transferase genotypes as risk factors for head and neck cancer. Am J Surg. 1995 Nov; 170(5):499-501.
    View in: PubMed
    Score: 0.001
  464. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov; 4(7):743-9.
    View in: PubMed
    Score: 0.001
  465. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9.
    View in: PubMed
    Score: 0.001
  466. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck. Curr Opin Oncol. 1995 May; 7(3):234-41.
    View in: PubMed
    Score: 0.001
  467. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 1995 May; 16(5):1243-5.
    View in: PubMed
    Score: 0.001
  468. Epidemiology, biology, and chemoprevention of aerodigestive cancer. Cancer. 1994 Nov 01; 74(9 Suppl):2719-25.
    View in: PubMed
    Score: 0.001
  469. Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 1994 Jun; 3(4):285-8.
    View in: PubMed
    Score: 0.001
  470. Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med. 1994 Feb; 90(2):55-9.
    View in: PubMed
    Score: 0.001
  471. Environmental carcinogenesis and its prevention: the head and neck cancer model. Cancer Res. 1993 May 01; 53(9):2189-91.
    View in: PubMed
    Score: 0.001
  472. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr; 2(2):103-6.
    View in: PubMed
    Score: 0.001
  473. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med. 1993 Mar; 22(3):101-8.
    View in: PubMed
    Score: 0.001
  474. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detect Prev. 1993; 17(6):575-83.
    View in: PubMed
    Score: 0.001
  475. Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control. 1992 Jul; 3(4):377-82.
    View in: PubMed
    Score: 0.001
  476. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec; 1(1):83-9.
    View in: PubMed
    Score: 0.001
  477. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21; 82(22):1773-5.
    View in: PubMed
    Score: 0.001
  478. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):467-76.
    View in: PubMed
    Score: 0.001
  479. A case-control study of prostate cancer. Am J Epidemiol. 1989 Aug; 130(2):395-8.
    View in: PubMed
    Score: 0.001
  480. Cancer and age. Semin Oncol. 1989 Feb; 16(1):3-9.
    View in: PubMed
    Score: 0.001
  481. Season-of-birth and acute leukemia of infancy. Chronobiol Int. 1989; 6(3):285-9.
    View in: PubMed
    Score: 0.001
  482. Nitrite inhalants: historical perspective. NIDA Res Monogr. 1988; 83:1-14.
    View in: PubMed
    Score: 0.000
  483. Childhood nervous system tumors--an evaluation of the association with paternal occupational exposure to hydrocarbons. Am J Epidemiol. 1987 Oct; 126(4):605-13.
    View in: PubMed
    Score: 0.000
  484. Subfertility: an etiologic factor in development of testicular cancer? Urology. 1987 Sep; 30(3):199-200.
    View in: PubMed
    Score: 0.000
  485. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987 Aug; 79(2):259-62.
    View in: PubMed
    Score: 0.000
  486. Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. J Natl Cancer Inst. 1987 May; 78(5):881-5.
    View in: PubMed
    Score: 0.000
  487. Epidemiologic similarities leading to etiologic hypotheses. Princess Takamatsu Symp. 1987; 18:173-80.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.